{"id":"mmr-0d-hpv-1m-hpv-7m","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain, swelling, or erythema"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Myalgia or arthralgia"},{"rate":null,"effect":"Rash"}]},"_chembl":{"chemblId":"CHEMBL5425888","moleculeType":null,"molecularWeight":"310.83"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The MMR vaccine contains live attenuated viruses that stimulate cellular and humoral immune responses against measles, mumps, and rubella. The HPV vaccine (administered at 1 month and 7 months) contains recombinant viral-like particles that elicit antibody responses against human papillomavirus types associated with cervical cancer and other malignancies. Together, this schedule provides comprehensive protection against these vaccine-preventable diseases.","oneSentence":"This is a vaccination schedule combining MMR (measles, mumps, rubella) and HPV (human papillomavirus) vaccines to provide immunization against these viral infections.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:55:37.958Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of measles, mumps, and rubella"},{"name":"Prevention of human papillomavirus-related cancers and diseases"}]},"trialDetails":[{"nctId":"NCT05279248","phase":"PHASE4","title":"The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella Vaccine","status":"UNKNOWN","sponsor":"Zhejiang Provincial Center for Disease Control and Prevention","startDate":"2021-08-25","conditions":"Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18, Measles","enrollment":300}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"MMR（0d），HPV（1m），HPV（7m）","genericName":"MMR（0d），HPV（1m），HPV（7m）","companyName":"Zhejiang Provincial Center for Disease Control and Prevention","companyId":"zhejiang-provincial-center-for-disease-control-and-prevention","modality":"Biologic","firstApprovalDate":"","aiSummary":"This is a vaccination schedule combining MMR (measles, mumps, rubella) and HPV (human papillomavirus) vaccines to provide immunization against these viral infections. Used for Prevention of measles, mumps, and rubella, Prevention of human papillomavirus-related cancers and infections.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}